2023
DOI: 10.1002/jso.27299
|View full text |Cite
|
Sign up to set email alerts
|

Colorectal cancer screening: A review of current screening options, timing, and guidelines

Abstract: Screening for colon and rectal cancer has been associated with reduced incidence over the past few decades. However, shown a paradoxical increase in colon and rectal cancer in those younger than 50 years has also been recently shown. This information, along with the introduction of new screening modalities, has lead to updates in the current recommendations. We present some of the data supporting the use of current screening modalities, as well as summarize current guidelines.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 71 publications
0
1
0
1
Order By: Relevance
“…However, patients with risk factors for CRC are included in high-screening programs. Furthermore, individuals with abnormal findings such as cancer or polyps should undergo surveillance colonoscopy regardless of their age[ 13 ]. Figure 1 summarizes the most updated societal recommendations for the screening of CRC.…”
Section: Introductionmentioning
confidence: 99%
“…However, patients with risk factors for CRC are included in high-screening programs. Furthermore, individuals with abnormal findings such as cancer or polyps should undergo surveillance colonoscopy regardless of their age[ 13 ]. Figure 1 summarizes the most updated societal recommendations for the screening of CRC.…”
Section: Introductionmentioning
confidence: 99%
“…5,6 Neste contexto, a introdução de estratégias de rastreamento, com a realização de exames periódicos para a detecção precoce do CCR, aumenta a possibilidade de tratamento potencialmente curativo e tem impacto no prognóstico destes pacientes. 7,8 A sobrevida global (SG) e a sobrevida livre de doença (SLD) de pacientes com CCR tem melhorado nas últimas décadas, especialmente em países com alta renda per capita. A SG em 5 anos de pacientes com CCR em países como Austrália, Canadá, Estados Unidos da América e vários países europeus, tem alcançado 65%, incluindo pacientes em todos os estadiamentos clínicos.…”
unclassified